PART I Overview As of December 31, 2025, we manage and operate a diverse portfolio of four (4) wholly owned subsidiaries across the medical aesthetics and biopharmaceutical sectors: Northstrive Biosciences Inc. (Northstrive Biosciences) is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. Our lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesitys pressing issue of pres...
| Type | Subject | Detail | Quarter |
|---|
| topic_mention | ELAB | discussed_in_filing Artificial Intelligence | |
| topic_mention | ELAB | discussed_in_filing Data Center | |
| topic_mention | ELAB | discussed_in_filing Cloud Computing | |
| topic_mention | ELAB | discussed_in_filing Cybersecurity | |
| topic_mention | ELAB | discussed_in_filing Trusted Computing | |
| topic_mention | ELAB | discussed_in_filing Blockchain & Crypto | |
| topic_mention | ELAB | discussed_in_filing Semiconductor | |
| topic_mention | ELAB | discussed_in_filing Capital Expenditure | |
| topic_mention | ELAB | discussed_in_filing Supply Chain | |
| topic_mention | ELAB | discussed_in_filing Regulation | |
| topic_mention | ELAB | discussed_in_filing Automotive | |
| topic_mention | ELAB | discussed_in_filing Healthcare & Bio | |
| topic_mention | ELAB | discussed_in_filing AI Compute | |
| topic_mention | ELAB | discussed_in_filing Platform & Ecosystem | |
| topic_mention | ELAB | discussed_in_filing Networking | |
| topic_mention | ELAB | discussed_in_filing Sovereign & Government | |
| topic_mention | ELAB | discussed_in_filing Artificial Intelligence | |
| topic_mention | ELAB | discussed_in_filing Data Center | |
| topic_mention | ELAB | discussed_in_filing Cloud Computing | |
| topic_mention | ELAB | discussed_in_filing Cybersecurity | |
This is the free public profile. For structured JSON with full provenance chain, use the API: